Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
In this podcast interview, John Villafranco--a partner in Washington with the law firm Kelley Drye & Warren LLP--describes the "tremendous state of flux" at the Federal Trade Commission and the potential implications for the dietary supplement industry.
In this podcast interview with Josh Long, INSIDER's legal editor, John Villafranco—a partner in Washington with the law firm Kelley Drye & Warren LLP—describes the “tremendous state of flux” at the Federal Trade Commission (FTC or Commission) and the potential implications for the dietary supplement industry. Among other topics, Villafranco weighs in on:
-- The historical role of the Commission;
-- FTC’s current makeup;
-- changes adopted by interim FTC chairwoman Maureen Ohlhausen;
-- potential names to lead the Commission;
-- The significance of a 2015 court decision in favor of Bayer and against the Commission; and
-- pending litigation against Quincy Bioscience over Prevagen, a supplement marketed to improve memory.
Villafranco will be speaking on Tuesday, Sept. 26, during a workshop at SupplySide West in Las Vegas. The workshop “Regulators and the Regulated,” will explore the Trump administration’s new FTC, lawsuits and investigations brought against the industry by state attorneys general, and the benefits of self-regulatory initiatives.
About the Author(s)
You May Also Like
Recommended
Sponsored Content
May 1, 2024
.png?width=800&auto=webp&quality=80&disable=upscale)